(12:01 GMT) Taysha Gene Therapies Price Target Raised to $15.00/Share From $12.00 by Baird
DO Dow Jones Newswires Taysha Gene Therapies Is Maintained at Outperform by Baird 6/30/2026, 08:01 PM GMT+8 Dow Jones Newswires TS TSHA (12:01 GMT) Taysha Gene Therapies Price Target Raised to $15.00/Share From $12.00 by Baird Market News Dow Jones Newswires Taysha Gene Therapies Price Target Maintained With a $11.00/Share by Citizens Dow Jones Newswires Taysha Gene Therapies Is Maintained at Buy by Needham TradingView Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $13, Implies 105% Upside
